ET-02 EFFICACY OF THE SALVAGE THERAPY VIA LOMUSTINE AND NIMUSTINE FOR RECURRENT GLIOBLASTOMA WITH TEMOZOLOMIDE RESISTANCE

por Yamamuro, Shun, Ichimura, Koichi, Takahashi, Masamichi, Tomiyama, Arata
Publicado no Neurooncol Adv (2019)

Observing deep radiomics for the classification of glioma grades

por Kobayashi, Kazuma, Miyake, Mototaka, Takahashi, Masamichi, Hamamoto, Ryuji
Publicado no Sci Rep (2021)

Spontaneous Rupture of the Omental Artery Treated by Transcatheter Arterial Embolization

por Takahashi, Masamichi, Matsuoka, Yujiro, Yasutake, Tsuyoshi, Abe, Hiroyuki, Sugiyama, Kazuhiro, Oyama, Kazuyuki
Publicado em 2012

Left ventricular wall findings in non-electrocardiography-gated contrast-enhanced computed tomography after extracorporeal cardiopulmonary resuscitation

por Sugiyama, Kazuhiro, Takahashi, Masamichi, Miyazaki, Kazuki, Ishida, Takuto, Kobayashi, Mioko, Hamabe, Yuichi
Publicado no Crit Care (2019)

NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR

por Yahiro, Sachiko, Matsuoka, Aiko, Miyakita, Yasuji, Ohno, Makoto, Takahashi, Masamichi, Narita, Yoshitaka
Publicado no Neurooncol Adv (2019)

Chylothorax treated with targeted sclerotherapy by direct puncture of the lymphatic leakage site

por Takahashi, Masamichi, Inoue, Masanori, Wada, Tomoki, Kawai, Go, Machida, Munetaka, Matsuoka, Yujiro
Publicado no Radiol Case Rep (2020)

GCT-46. MULTI-KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS AGAINST INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS

por Uchida, Eita, Ozawa, Tatsuya, Takahashi, Masamichi, Nishikawa, Ryo, Ichimura, Koichi, Tomiyama, Arata
Publicado no Neuro Oncol (2020)

Glandulocalyx upatoiensis, a fossil flower of Ericales (Actinidiaceae/Clethraceae) from the Late Cretaceous (Santonian) of Georgia, USA

por Schönenberger, Jürg, von Balthazar, Maria, Takahashi, Masamichi, Xiao, Xianghui, Crane, Peter R., Herendeen, Patrick S.
Publicado em 2012

Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein

por Ikushima, Hiroaki, Todo, Tomoki, Ino, Yasushi, Takahashi, Masamichi, Saito, Nobuhito, Miyazawa, Keiji, Miyazono, Kohei
Publicado em 2011

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years

por Ohno, Makoto, Miyakita, Yasuji, Takahashi, Masamichi, Igaki, Hiroshi, Matsushita, Yuko, Ichimura, Koichi, Narita, Yoshitaka
Publicado no Radiat Oncol (2019)

Evolution of a key trait greatly affects underground community assembly process through habitat adaptation in earthworms

por Ikeda, Hiroshi, Fukumori, Kayoko, Shoda‐Kagaya, Etsuko, Takahashi, Masamichi, Ito, Masamichi T., Sakai, Yoshimi, Matsumoto, Kazuma
Publicado no Ecol Evol (2018)

NQPC-14 COMPARISON OF QOL SCALES IN PATIENTS WITH BRAIN TUMORS

por Satomi, Natsuko Tsushita, Miyahara, Ruriko, Omura, Takaki, Takahashi, Masamichi, Ohno, Makoto, Miyakita, Yasuji, Narita, Yoshitaka
Publicado no Neurooncol Adv (2019)

The presumed ginkgophyte Umaltolepis has seed-bearing structures resembling those of Peltaspermales and Umkomasiales

por Herrera, Fabiany, Shi, Gongle, Ichinnorov, Niiden, Takahashi, Masamichi, Bugdaeva, Eugenia V., Herendeen, Patrick S., Crane, Peter R.
Publicado no Proc Natl Acad Sci U S A (2017)

QOLP-40. END-OF-LIFE CARE FOR GLIOBLASTOMA PATIENTS IN JAPAN

por Omura, Tomoko, Miyakita, Yasuji, Ohno, Makoto, Takahashi, Masamichi, Fujimoto, Kenji, Omura, Takaki, Sato, Hitomi, Narita, Yoshitaka
Publicado no Neuro Oncol (2019)

ET-09 ACQUIRED MALIGNANT BEHAVIORS OF NPE6-PDT-SURVIVED GLIOBLASTOMA CELLS ARE SUPPRESSED BY USING MEK1/2 INHIBITOR TRAMETINIB

por Kobayashi, Tatsuya, Muragaki, Yoshihiro, Takahashi, Masamichi, Wada, Kojiro, Mori, Kentaro, Kawamata, Takakazu, Ichimura, Koichi, Tomiyama, Arata
Publicado no Neurooncol Adv (2019)

NQPC-10 END-OF-LIFE PHASE OF GLIOBLASTOMA

por Omura, Tomoko, Miyakita, Yasuji, Omura, Takaki, Ohno, Makoto, Takahashi, Masamichi, Satomi, Natsuko, Fujimoto, Kenji, Narita, Yoshitaka
Publicado no Neurooncol Adv (2019)

ACT-01 THE SECOND GENERATION ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITOR CERITINIB EFFECTIVELY INDUCES CELL DEATH IN HUMAN GLIOBLASTOMA CELLS

por Kawauchi, Daisuke, Takahashi, Masamichi, Yamamuro, Shun, Kobayashi, Tatsuya, Uchida, Eita, Iwadate, Yasuo, Ichimura, Koichi, Tomiyama, Arata
Publicado no Neurooncol Adv (2019)

COT-04 FAMILY SUPPORT FOR PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS BY PATIENT SUPPORT GROUP IN NATIONAL CANCER CENTER

por Horikawa, Mayumi, Kishi, Tatsuya, Ishii, Kazumi, Mori, Ayako, Narita, Yoshitaka, Miyakita, Yasuji, Ohno, Makoto, Takahashi, Masamichi
Publicado no Neurooncol Adv (2019)

COT-23 INITIAL EXPERIENCE OF TREATMENT FOR GLIOBLASTOMA BY NOVO-TTF

por Omura, Takaki, Miyakita, Yasuji, Ohno, Makoto, Takahashi, Masamichi, Satomi, Natsuko, Fujimoto, Kenji, Omura, Tomoko, Narita, Yoshitaka
Publicado no Neurooncol Adv (2019)

ET-05 Alectinib and ceritinib, the second-generation ALK inhibitors, effectively induce glioblastoma cell death

por Kawauchi, Daisuke, Takahashi, Masamichi, Yamamuro, Shun, Kobayashi, Tatsuya, Uchida, Eita, Iwadate, Yasuo, Ichimura, Koichi, Tomiyama, Arata
Publicado no Neurooncol Adv (2020)